NeuroSync Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Series A3
  • (In Progress)

  • Latest Deal Amount
  • $10M

  • Investors
  • 5

NeuroSync General Information

Description

Developer of a digital health platform designed for brain health and performance applications. The company's platform offers customizable technology leveraging artificial intelligence and objective measures, enabling clinicians, researchers, and high-performance specialists to utilize actionable data for identifying neurological deficits, monitoring responses to treatments, and planning targeted training programs.

Contact Information

Formerly Known As
SyncThink
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 118 Washington Street
  • Suite 14
  • Holliston, MA 01746
  • United States
+1 (855)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 118 Washington Street
  • Suite 14
  • Holliston, MA 01746
  • United States
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroSync Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A3) 17-May-2023 $10M In Progress Generating Revenue
8. Later Stage VC (Series A2) 20-Nov-2020 Completed Generating Revenue
7. Debt - PPP 15-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series A1) 10-Dec-2018 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
4. Accelerator/Incubator 13-Jun-2017 Completed Generating Revenue
3. Seed Round 12-Dec-2016 Completed Generating Revenue
2. Accelerator/Incubator 24-Oct-2014 $1M $1M Completed Pre-Clinical Trials
1. Grant 01-Jan-2012 $20M Completed Startup
To view NeuroSync’s complete valuation and funding history, request access »

NeuroSync Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
To view NeuroSync’s complete cap table history, request access »

NeuroSync Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital health platform designed for brain health and performance applications. The company's platform of
Diagnostic Equipment
Holliston, MA
43 As of 2026

Rockville, MD
 

New Richmond, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeuroSync Competitors (3)

One of NeuroSync’s 3 competitors is BrainScope, a Venture Capital-Backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BrainScope Venture Capital-Backed Rockville, MD
Oculogica Venture Capital-Backed New Richmond, WI
RightEye Venture Capital-Backed Bethesda, MD
You’re viewing 3 of 3 competitors. Get the full list »

NeuroSync Patents

NeuroSync Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210219838-A1 System and method for detection and quantification of impairment due to cannabis use Inactive 21-Jan-2020
US-20160302713-A1 System and method for concussion detection and quantification Inactive 15-Apr-2015
WO-2016168724-A1 System and method for concussion detection and quantification Inactive 15-Apr-2015
US-20150208975-A1 System and method for target independent neuromotor analytics Inactive 29-Jan-2014
US-20150126899-A1 System and method for dynamic cognitive training Active 06-Nov-2013 G09B5/02
To view NeuroSync’s complete patent history, request access »

NeuroSync Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroSync Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Mitsubishi Chemical Advanced Materials Corporation Minority
Oceanic Partners Venture Capital Minority
StartUp Health Venture Capital Minority
Brain Trauma Foundation Other
To view NeuroSync’s complete investors history, request access »

NeuroSync FAQs

  • When was NeuroSync founded?

    NeuroSync was founded in 2008.

  • Where is NeuroSync headquartered?

    NeuroSync is headquartered in Holliston, MA.

  • What is the size of NeuroSync?

    NeuroSync has 43 total employees.

  • What industry is NeuroSync in?

    NeuroSync’s primary industry is Diagnostic Equipment.

  • Is NeuroSync a private or public company?

    NeuroSync is a Private company.

  • What is the current valuation of NeuroSync?

    The current valuation of NeuroSync is .

  • What is NeuroSync’s current revenue?

    The current revenue for NeuroSync is .

  • How much funding has NeuroSync raised over time?

    NeuroSync has raised $14.5M.

  • Who are NeuroSync’s investors?

    , Mitsubishi Chemical Advanced Materials, Oceanic Partners, StartUp Health, and Brain Trauma Foundation have invested in NeuroSync.

  • Who are NeuroSync’s competitors?

    BrainScope, Oculogica, and RightEye are competitors of NeuroSync.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process